** = Publications listed in SCI/SSCI/Pubmed
** Resch, B; Gusenleitner, W; Mueller, WD
Risk of concurrent bacterial infection in preterm infants hospitalized due to respiratory syncytial virus infection.
ACTA PAEDIAT. 2007; 96(4): 495-498.
Doi: 10.1111/j.1651-2227.2007.00226.x
Web of Science
PubMed
FullText
FullText_MUG
** Resch, B; Gusenleitner, W; Müller, WD; Haas, J
Observational study of respiratory syncytial virus-associated hospitalizations and use of palivizumab in premature infants aged 29-32 weeks.
EUR J CLIN MICROBIOL INFECT D. 2006; 25(2): 120-122.
Doi: 10.1007/s10096-005-0082-y
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Resch, B; Pasnocht, A; Gusenleitner, W; Müller, W
Rehospitalisations for respiratory disease and respiratory syncytial virus infection in preterm infants of 29-36 weeks gestational age.
J Infect. 2005; 50(5):397-403
Doi: 10.1016/j.jinf.2004.06.015
Web of Science
PubMed
FullText
FullText_MUG
** Resch, B; Gusenleitner, W; Müller, WD
Procalcitonin and interleukin-6 in the diagnosis of early-onset sepsis of the neonate.
Acta Paediatr. 2003; 92(2):243-245
Doi: 10.1097%2F00006454-200305000-00024
Web of Science
PubMed
FullText
FullText_MUG